Iptacopan in Patients With ANCA Associated Vasculitis

PHASE2RecruitingINTERVENTIONAL
Enrollment

78

Participants

Timeline

Start Date

August 5, 2024

Primary Completion Date

September 9, 2027

Study Completion Date

October 5, 2027

Conditions
Anti-Neutrophil Cytoplasm Antibodies (ANCA) Associated Vasculitis
Interventions
DRUG

Iptacopan

LNP023 administered orally

DRUG

Placebo

Matching placebo administered orally

DRUG

Rituximab

Standard of care

Trial Locations (55)

1090

RECRUITING

Novartis Investigative Site, Vienna

2139

RECRUITING

Novartis Investigative Site, Concord

2145

RECRUITING

Novartis Investigative Site, Westmead

3000

RECRUITING

Novartis Investigative Site, Leuven

3168

RECRUITING

Novartis Investigative Site, Clayton

4032

RECRUITING

Novartis Investigative Site, Debrecen

5000

RECRUITING

Novartis Investigative Site, Adelaide

6020

RECRUITING

Novartis Investigative Site, Innsbruck

6720

RECRUITING

Novartis Investigative Site, Szeged

8036

RECRUITING

Novartis Investigative Site, Graz

8200

RECRUITING

Novartis Investigative Site, Aarhus N

8800

RECRUITING

Novartis Investigative Site, Roeselare

10028

RECRUITING

Northwell Health, New York

10600

RECRUITING

Novartis Investigative Site, Plasencia

13353

RECRUITING

Novartis Investigative Site, Berlin

13385

RECRUITING

Novartis Investigative Site, Marseille

21034

RECRUITING

Novartis Investigative Site, Dijon

28046

RECRUITING

Novartis Investigative Site, Madrid

29200

RECRUITING

Novartis Investigative Site, Brest

31008

RECRUITING

Novartis Investigative Site, Pamplona

31054

RECRUITING

Novartis Investigative Site, Toulouse

34899

RECRUITING

Novartis Investigative Site, Istanbul

49933

RECRUITING

Novartis Investigative Site, Angers

55131

RECRUITING

Novartis Investigative Site, Mainz

55905

RECRUITING

Mayo Clinic Rochester, Rochester

67063

RECRUITING

Novartis Investigative Site, Ludwigshafen

73230

RECRUITING

Novartis Investigative Site, Kirchheim unter Teck

75014

RECRUITING

Novartis Investigative Site, Paris

79106

RECRUITING

Novartis Investigative Site, Freiburg im Breisgau

81377

RECRUITING

Novartis Investigative Site, Munich

85202

RECRUITING

Arizona Arthritis and Rheumatology Research PLLC, Mesa

90095

RECRUITING

UCLA Medical Center, Los Angeles

100034

ACTIVE_NOT_RECRUITING

Novartis Investigative Site, Beijing

200032

RECRUITING

Novartis Investigative Site, Shanghai

450052

RECRUITING

Novartis Investigative Site, Zhengzhou

C1180AAX

RECRUITING

Novartis Investigative Site, CABA

C1181ACH

RECRUITING

Novartis Investigative Site, CABA

B1900AWT

RECRUITING

Novartis Investigative Site, La Plata

N6A 5W9

RECRUITING

Novartis Investigative Site, London

J1H 5N4

RECRUITING

Novartis Investigative Site, Fleurimont

H2X 1R9

RECRUITING

Novartis Investigative Site, Montreal

H4J 1C5

RECRUITING

Novartis Investigative Site, Montreal

G1R 2J6

RECRUITING

Novartis Investigative Site, Québec

050000

RECRUITING

Novartis Investigative Site, Shijiazhuang

128 08

RECRUITING

Novartis Investigative Site, Prague

DK-2100

RECRUITING

Novartis Investigative Site, Copenhagen

DK-2730

RECRUITING

Novartis Investigative Site, Herlev

H-1083

RECRUITING

Novartis Investigative Site, Budapest

9713 GZ

RECRUITING

Novartis Investigative Site, Groningen

06230

RECRUITING

Novartis Investigative Site, Ankara

06500

RECRUITING

Novartis Investigative Site, Ankara

BD5 0NA

RECRUITING

Novartis Investigative Site, Bradford

CB2 0QQ

ACTIVE_NOT_RECRUITING

Novartis Investigative Site, Cambridge

LE5 4PW

RECRUITING

Novartis Investigative Site, Leicester

SE5 9RS

RECRUITING

Novartis Investigative Site, London

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY